Export feasibility of hand sanitisers examined by CDSCO

The Central Drugs Standard Control Organisation (CDSCO) has instructed the Drug Controllers of all the States and Union Territories (UT) to submit the details after assessing the production capacity and sufficiency of availability of hand sanitisers in the domestic market by the afternoon of May 15, 2020.

Following details have to be furnished by State Drug Controllers:-

1.- Name and address of manufacturers
2.- Average per month production capacity (in litres) of each manufacturer
3.- Average actual monthly production in April 2020 (in litres)
4.- Has the firm fulfilled the domestic supply request ?
5.- Does the manufacturer have suuficient supply and availability of raw materials like ethanol, IPA etc., for manufacturing and production?

If an excess is available after fulfilment of the domestic request, how much (in litres)?
After assessment CDSCO has also asked each Drug Controller to prepare a summary data which will inform about the sufficient availability of hand sanitisers in their respective States and UTs. The data should also be based upon whether the hand sanitisers are being produced by firms in quantities that exceed the demand in domestic markets of India.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre